Semaglutide improves cardiovascular health independently of body-composition research [PMID: 39196231] Laboratory literature summary: Semaglutide improves cardiovascular health independently of body-composition research
Deloose, E., Vos, R., Corsetti, M., Depoortere, I
The most pronounced effects were observed in glial cells, the metabolic and inflammatory support system of the brain, suggesting that improving the brains environment may be as important as targeting neurons directly
Tumor necrosis factor in myocardial hypertrophy and ischaemiaan anti-apoptotic perspective
Therapy with GLP-1RA should therefore start with low doses that can be uptitrated ( GLP-1RA has been placed prominently in the international recommendations for the treatment of T2D as the first injectable agent before insulin due to the advantageous outcomes in cardiovascular safety studies that demonstrated a reduction of the combined cardiovascular endpoint three-component major adverse cardiovascular event (MACE-3